Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

8 adopted * Africa

12th World AIDS Conference

--Keyword Abstr
cy to planning a future: Adopting the identity of a chronically ill per
g political commitment: a national AIDS policy framewor
awian youth/Barriers to adopting HIV risk-reduction behaviours in
or HIV/AIDS prevention enter-education strategies/Yout
ith CMV retinitis after of 1996 IAS-USA recommendati
n HIV-infected children/ Adrenal insufficiency secondary to meges
herapeutic adherence/ Adult social identity is part of culturally co
ral therapy naive Thai adult population with CD4 counts 150-350

ulation/7-year trends in
1996/Characteristics of
ce of focus groups with
eceptor expression in
pects of tuberculosis in
P. carinii and T. gondii in
inst in HIV seropositive
rienced HIV-1 infected
nfection among young
adolescent and young
cal reference ranges for
sitive and HIV-negative
cio-economic impact of
f HIV interventions with
al pressure in Ugandan
DDC (Retrovir-Hivid) in
lized African-American
razil/AIDS mortality in
es in otherwise healthy
women observed in the

HIV-1 prevalence, incidence and mo
HIV-infected female tuberculosis pati
men and women on sexuality in Paki
Simian astrocytes cultures/Chemota
AIDS patients in Rio de Janeiro, Braz
HIV-1 infected individuals with stable
patients/Immunogenicity of hepatitis
patients/Same antiretroviral combin
recently initiated injection drug users
recently initiated injection drug users
HIV Ethiopians: Effects of HIV-1 infe
patients in Kenyatta National Hospita
mortality and morbidity on household

act
24263
43570
14195
33559
12158
32445
32355
12241
13106
13250
14241
21144
22142
22179
22327
22382
23168
23191
31183
42446
44206

ulgarian seropositives/ Advanced stage of HIV infection among n 42136
m Korean patients with advanced AIDS/Determination of genetic 11201
a cohort of patients with HIV infection, in Lima-Peru/Epi 12122
nical manifestations of HIV disease using hospital surv 12146
view of the patients with HIV disease in Bulgaria/Clinical 12150
uential therapy in naive HIV patients: The MASTER Stu 12243
ediatric patients with HIV disease/Combinations of di 12253
n and adolescents with HIV infection/Combination ther 12262
V-infected patients with immunodeficiency started on pr 440*/12266
n as salvage therapy in HIV disease/Combined nelfina 12303
naive patients with very disease (trial ISS 047)/Correlati 12363
naive patients with very disease/Quality of life before an 12444
umonia in patients with HIV disease/High prevalence o 22117
disease in patients with AIDS is decreased among thos 22145
node morphology after AIDS following antiretroviral trip 22389
conomic aspects of the HIV infection/Effect of the new 22392
herapy in patients with HIV disease on highly active ant 345*/22412
ers and patients about directives (AD) in a teaching ho 22430
ansmission of HIV-1 in HIV disease and advanced peri 23401
V-1 CTLm responses in infection/Prolonged suppressio 112*/31124
ance of skin allografts in HIV infected patients/Toleranc 31182
cal disturbances during HIV-1 infection/Antigen p24 HI 32222
erapy in a US inner city, AIDS population. Will viral rebo 32405
asma RNA changes in patients after 6 months of triple t 41140
tiretroviral therapies at stages of HIV disease/Dynamic 41179
ndrosterone (DHEA) in HIV-infected patients/Double bl / 42326
udy (1997)/The recent treatment of AIDS terminal case 42383
Is in AIDS patients with HIV disease from the CPCRA 0 60508
and d4T in patients with HIV disease/Saquinavir (SQV) i 60714
agement: What is real?/ Advances in HIV management: What is re 44250
ging the gap for clients/ in HIV/substance abuse treatm 60072
en in the UK/Treatment advances,risk taking and HIV testing histo 14159
al men/AIDS treatment and perceived need to maintain 23403
3 year analysis/Recent in antiviral therapy (ARV) for HI 24136
s to condom use - New in condom technology/Overco 33112
f HIV/AIDS treatment on community based AIDS servi 34310
the future in the light of in combination drug treatment/ 34315
reas/Responding to in HIV treatment: Planned chan 42415

-Keyword

Abstract--

heterosexually active men/A review 254*/44303

AIDS patients with cryptococcal men
HIV(+)/AIDS naive patients/CD4 ma
patients with HIV disease/The "do n
patients in the last 3 years: Decreasi
HIV-1 infected individuals/Chronic u
and adolescent spectrum of disease

60231
60235
60287
60580
60648
60923
447*/22126
12143

s in HIV+;, Tuberculin+ Adults (CPCRA004/ACTG177/CDC/PAH
cohort of HIV-1 infected adults in Uganda/Outcome and cause of d

iral naive, HIV-infected
tomatic HIV-1 infected
nversion among young
adolescents and young
pulmonary tuberculous
IV-infected Ugandan
nergic and non-anergic
mong youths and young
life issues among older
DS education for young
isk behaviour among
of seriously mentally ill
tion program for young
cobacteremia in febrile
CAP) among Ugandan
IV-1 infected Ugandan
dicator disease among
ohort of HIV-1 infected
al population of 15,000
practice of HIV-infected
of HIV risk behaviors in
IV risk behavior among
dolescents and young
adolescents and young
I profile of HIV-infected
ement for multi-grieved
IV-1-infected Ugandan
matic HIV-infected Thai
s in HIV-1 seropositive
ea among HIV infected
bel use of thalidomide in
sample of HIV-infected
arginally housed (H/M)
dolescent and young
adolescents and young
mples from Tanzanian
stable anti-HIV drug, in, and viral load in HIV+
al health of HIV infected
y quality in HIV infected
dy mass in HIV-infected
n HIV testing among US
V testing history among
ds assessment of older
oster virus infection in
on among HIV-infected
ocyte subsets for HIV+
antibody in HIV-infected
agents in HIV infected

/Hydroxyurea in combination regim 287*/12235
in Nairobi, Kenya/Evaluation of the 12407
in the US Army, 1985-1996: Curren 518*/13212
in the United States/Trends in HIV i 13222,1993-1997, Kampala, Uganda/Tre 610*/13273
/Impact of pulmonary tuberculosis ( 13315
from a voluntary counselling and te 13324
/The epidemiological background f 13392
affected by HIV/Addressing extend 13398
in rural China: Operations research 13414
aged 18-25 years/Evaluation of a b 40*/14253
/Outcome of a cognitive-behavioral 14279
in Brazil/Why the prevention works 14290
admitted to Mulago hospital in Kam 22109: Impact of HIV-infection/Diagnosis 22116
/Ethambutol (EMB) in the continuati 454*/22140
in California/Gender-specific risk of 22185
in Entebbe, Uganda/Falciparum m 130*/22236
in southwest Uganda/Risk factors f 23356
in Australia/Treatments, intimacy a 641*/23402
with serious mental illness/Psychia 23531
living with a severe and persistent 23544
at the local level/Communities at ris 23546
/A survey of the mental health care 24230
in Montreal, 1990-1997/Retrospec 24233
and adolescents in a poor AIDS stri 24246
/Cross-clade HIV-1 specific cytotoxi 31139
with CD4+ T lymphocyte >500 cells 31158
in Kenya/Clinical evaluation of an a 31208
in Rwanda/Case-control etiological 32105
with HIV-associated wasting (Proto 32170
/Self-reported adherence to combin 32338
/Protease inhibitors (PI) are associa 32390
who recently initiated injection drug 33394
/Training increases service provide 34146
/Evaluation of an experimental Amp 41155
with symptomatic HIV infection/Th 42263
with CD4+ counts 200-499/mm3/E 42328
/The effect of protease inhibitors on 42346
/Ecological and attitudinal influence 42348
using progressive resistance trainin 42357
1993 to 1996/Trends in HIV testing 43127
in the United States/HIV testing hist 43140
in caring for persons living with AID 44219
in the large city/Varicella zoster viru 60267
in care with indications for antiretrov 60394
/Comparison between flow cytomet 60416
/Anti-GM2 mediated cytotoxic antib 60458
and adolescents"/In an era of const 60922

As to improve care in an advancing pandemic: Theta speaker's bur
ease inhibitors therapy/ Adverse reactions during protease inhibito
inical progression and adverse events in a cohort of HIV-infected
cife, Brazil/Tolerance, reactions and compliance of child
eporting scheme/HIV drug reaction (ADR) reporting sch
sages/Using television advertisements for social marketing of Al
ationwide public service advertising on STD syndromes/Developi
ine/Effects of different strategies for enhancing referr
ects of gender, medical advice and beliefs about efficacy and toxici
hysicians' and patients' advises about adherence to antiviral thera
e New York State AIDS Advisory Council/Ethical principles to ass
he National Community Board of the Women's Interagen
he National Community Board of the Women's Interagen
exploitation of PLWHA/ Advocacy against exploitation of PLWHA/

22479
60658
440*/12266
12333
12385
33488
588*/33450
33494
32318
60481
44125
44264
44278
34287

with HIV/AIDS in Peru/ workshops: Creating effective 34306
and improved survival/ for poverty alleviation as an alte 44228
ducation, activism and advocacy for parents of HIV+ children: Th 32441
perspective/Treatment for people with HIV/AIDS: A Hon 34279
oking ahead: A national coalition explores its future/Loo 34378
policy development and: A Kenya AIDS NGOs consortiu 43566
atemala/Human rights:Ensuring HIV/AIDS prevention 404*/44146
e system: The need for /Adolescents living with HIV and 44287
Women, HIV/AIDS and: Setting priorities/Women, HIV/ 60081
ncy culture"/Peer group and the "dependency culture"/P 60420
ncy culture"/Peer group and the "dependency culture"/P 60885
e Canadian Treatment Advocates Council/Swimming with the sh 42238
0-499/mm3/Effects of aerobic and resistive exercise training on 42328
tient with HIV infection/ Aerococcus viridans as a causative agent 32263
iral therapy/The role of aerosolized pentamidine prophylaxis in th 22182
nia in HIV disease/The aetiology and natural history of neutropeni 32152
kers need to know/The affordability of antiretroviral therapy in de 481*/44245
pportunistic infections/ Affordable medical care for HIV/AIDS pati 69*/42425
AIDS diagnoses, and is affordable /Expansion of US Medicaid sys 482*/44241
pes in West and Central Africa /Molecular epidemiology of HIV-1 g 430*/11163
n untreated infants from /Viral load studies in untreated infan 12154
ospital (CHBH), South /The impact of HIV infection on in-h 172*/12166
urban hospital in South /The effect of HIV on gastro-enteritis 12174
n of HIV-1 and HIV-2 in: The role of unsterile injections in th 13107
ape provinces of South /Molecular epidemiology of HIV-1 in 13125
people in sub-Saharan /Cost-effectiveness of isoniazid pre 450*/13278
V-2 in the Gambia, West /A comparison of survival between 13294

ir dipivoxil (Preveon", ADV ) in combinations with indinavir (IDV),

22371

ditions in distinct South

patient populations/Incidence and c

13381